Enzo Begins Marketing Dx Test for Early Lung Cancer Detection
Enzo Clinical Labs this week launched a diagnostic test to help oncologists detect lung cancer early and gauge which patients are at heightened risk for disease progression.
The company is launching the blood-based test, called EarlyCDT-Lung, through its clinical laboratory in the New York metropolitan market, in New Jersey, and in Eastern Pennsylvania. The New York State Department of Health has approved the lab-developed test to be marketed to residents.